Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabe S Sonke

Showing results (1-10 of 218) with videos related to

Pageof 22
Sort By:
Clinical Advances in Hematology & Oncology : H&O|August 2, 2023
Novel sources of funding for clinical trials in oncologyGabe S Sonke
The American Journal of Cardiology|May 12, 2007
Lower pre-hospital case fatality after myocardial infarction creates a survival benefit for women compared with menGabe S Sonke
BMJ (Clinical Research Ed.)|March 27, 2014
Optimising end of life care requires an individualised approachHilde M Buiting, Gabe S Sonke
The New England Journal of Medicine|November 14, 2009
Isolated tumor cells in breast cancerGabe S Sonke, Sabine C Linn
Journal of Surgical Oncology|February 6, 2024
Gray oncologic areasHilde M Buiting, Gabe S Sonke
The Yale Journal of Biology and Medicine|July 1, 2024
Setting the Stage for Cancer: Stay Soft and OptimisticHilde M Buiting, Gabe S Sonke
Journal of Surgical Oncology|March 27, 2024
NaturalHilde M Buiting, Gabe S Sonke
The New England Journal of Medicine|May 14, 2015
Treatment of HER2-positive metastatic breast cancerMette S van Ramshorst, Gabe S Sonke
The New England Journal of Medicine|March 15, 2008
Cetuximab for colorectal cancerEllen van der Spek, Gabe S Sonke
Expert Review of Anticancer Therapy|October 21, 2020
Ribociclib plus fulvestrant in the treatment of breast cancerPatrick Neven, Gabe S Sonke, Guy Jerusalem
Pageof 22

Showing results (1-10 of 218) with videos related to

Sort By:
Pageof 22
Clinical Advances in Hematology & Oncology : H&O|August 2, 2023
Novel sources of funding for clinical trials in oncologyGabe S Sonke
The American Journal of Cardiology|May 12, 2007
Lower pre-hospital case fatality after myocardial infarction creates a survival benefit for women compared with menGabe S Sonke
BMJ (Clinical Research Ed.)|March 27, 2014
Optimising end of life care requires an individualised approachHilde M Buiting, Gabe S Sonke
The New England Journal of Medicine|November 14, 2009
Isolated tumor cells in breast cancerGabe S Sonke, Sabine C Linn
Journal of Surgical Oncology|February 6, 2024
Gray oncologic areasHilde M Buiting, Gabe S Sonke
The Yale Journal of Biology and Medicine|July 1, 2024
Setting the Stage for Cancer: Stay Soft and OptimisticHilde M Buiting, Gabe S Sonke
Journal of Surgical Oncology|March 27, 2024
NaturalHilde M Buiting, Gabe S Sonke
The New England Journal of Medicine|May 14, 2015
Treatment of HER2-positive metastatic breast cancerMette S van Ramshorst, Gabe S Sonke
The New England Journal of Medicine|March 15, 2008
Cetuximab for colorectal cancerEllen van der Spek, Gabe S Sonke
Expert Review of Anticancer Therapy|October 21, 2020
Ribociclib plus fulvestrant in the treatment of breast cancerPatrick Neven, Gabe S Sonke, Guy Jerusalem
Pageof 22